Analgesics..
Antiandrogens..
Bromhexine
Budesonide
Cannabidiol
Colchicine
Conv. Plasma
Curcumin
Ensovibep
Famotidine
Favipiravir
Fluvoxamine
Hydroxychlor..
Iota-carragee..
Ivermectin
Lactoferrin
Lifestyle..
Melatonin
Metformin
Molnupiravir
Monoclonals..
Nigella Sativa
Nitazoxanide
Nitric Oxide
Paxlovid
Peg.. Lambda
Povidone-Iod..
Quercetin
Remdesivir
Vitamins..
Zinc

Other
Feedback
Home
Home   COVID-19 treatment studies for Zinc  COVID-19 treatment studies for Zinc  C19 studies: Zinc  Zinc   Select treatmentSelect treatmentTreatmentsTreatments
Melatonin Meta
Bromhexine Meta Metformin Meta
Budesonide Meta Molnupiravir Meta
Cannabidiol Meta
Colchicine Meta Nigella Sativa Meta
Conv. Plasma Meta Nitazoxanide Meta
Curcumin Meta Nitric Oxide Meta
Ensovibep Meta Paxlovid Meta
Famotidine Meta Peg.. Lambda Meta
Favipiravir Meta Povidone-Iod.. Meta
Fluvoxamine Meta Quercetin Meta
Hydroxychlor.. Meta Remdesivir Meta
Iota-carragee.. Meta
Ivermectin Meta Zinc Meta
Lactoferrin Meta

Other Treatments Global Adoption
All Studies   Meta Analysis   Recent:  
Analysis of trace elements (Zn and Cu) levels in COVID-19 patients with ICU and Non-ICU hospitalization
Ram et al., Research Square, doi:10.21203/rs.3.rs-2418159/v1 (Preprint)
Ram et al., Analysis of trace elements (Zn and Cu) levels in COVID-19 patients with ICU and Non-ICU hospitalization, Research Square, doi:10.21203/rs.3.rs-2418159/v1 (Preprint)
Jan 2023   Source   PDF  
  Twitter
  Facebook
Share
  All Studies   Meta
Prospective analysis of 122 hospitalized COVID-19 patients, showing significantly lower zinc levels in ICU patients compared with non-ICU patients. Zinc levels were lower in non-survivors compared with survivors, without statistical significance.
Ram et al., 3 Jan 2023, prospective, preprint, 10 authors, study period July 2020 - November 2020.
All Studies   Meta Analysis   Submit Updates or Corrections
This PaperZincAll
Abstract: Analysis of trace elements (Zn and Cu) levels in COVID-19 patients with ICU and Non-ICU hospitalization Sant Ram (  drsantram2016@gmail.com ) Post Graduate Institute of Medical Education and Research Neha Saini Post Graduate Institute of Medical Education and Research Ram Krishan Saini Post Graduate Institute of Medical Education and Research Sandeep Kaur Post Graduate Institute of Medical Education and Research Piyush Pathak Post Graduate Institute of Medical Education and Research Ravjit Jassal Post Graduate Institute of Medical Education and Research Mohana Kumari Chidananda Post Graduate Institute of Medical Education and Research Deepy Zohmangaihi Post Graduate Institute of Medical Education and Research Shiv lal Soni Post Graduate Institute of Medical Education and Research Vikas Suri Post Graduate Institute of Medical Education and Research Research Article Keywords: Posted Date: January 3rd, 2023 DOI: https://doi.org/10.21203/rs.3.rs-2418159/v1 License:   This work is licensed under a Creative Commons Attribution 4.0 International License. Read Full License Page 1/17 Abstract Background: The persistence of the COVID-19 pandemic besides its current resurgence and continuously increasing fatalities indicates a vital need for severity assessment at its early stages. Recent studies have already ascribed mortality to chronic inflammation. But the part of trace elements, especially zinc and copper that have been known to possess antiviral roles for a long time is least studied in COVID-19. Methods: The study comprised 122 COVID-19-positive participants admitted to the tertiary care hospital. Among them, eighty-one (~66%) were admitted to ICU under high severity. Levels of Zn and Cu along with CRP were analyzed and compared among ICU and non-ICU admitted patients. Using ROC analysis, the potential and precise levels for defining severity were determined. Results: We found a significant reduction in Zn levels (p=0.001) in ICU-admitted patients compared to the non-ICU group which was more pronounced in females and patients aged above 50 years. Reduction in the levels of Zn is accompanied by elevated CRP levels (p<0.001) in ICU patients with no effect on Cu levels. Upon ROC analysis, Zn and CRP were found to have significant AUC (p<0.0001). Further, CRP to Zn ratio displayed improved AUC with 90% sensitivity indicating their applicability to predict ICU requirements. Conclusions: The present study was primarily aimed to predict the status of zinc and copper in COVID-19 patients and their utility as a prognostic tool for deciding the severity. Our findings indicate that CRP to Zn ratio might feasibly be used to predict the progression of COVID-19 toward severity. Keywords: COVID-19, Severity, Zinc, Copper, CRP
Loading..
Please send us corrections, updates, or comments. Vaccines and treatments are complementary. All practical, effective, and safe means should be used based on risk/benefit analysis. No treatment, vaccine, or intervention is 100% available and effective for all current and future variants. We do not provide medical advice. Before taking any medication, consult a qualified physician who can provide personalized advice and details of risks and benefits based on your medical history and situation. FLCCC and WCH provide treatment protocols.
  or use drag and drop   
Submit